AdBlock detected!\nPlease add www.getadmiral.com to your adblocking whitelist or disable your adblocking software.\n","anAlternativeClone":"2","anAlternativeProperties":"","anOptionModalShowAfter":0,"anPageMD5":"","anSiteID":0,"modalHTML":"\n\tThanks for visiting GEN\n\tWe noticed that you have an ad blocker on.\nAdvertisements help us provide quality content to you.\nPlease support us by whitelisting our website in your ad blocker.\nOk, I will whitelist the GEN website\n \n\n"}/* ]]> */Scroll UpLoginSubscribefunction genesisBlocksShare( url, title, w, h )var left = ( window.innerWidth / 2 )-( w / 2 );var top = ( window.innerHeight / 2 )-( h / 2 );return window.open(url, title, 'toolbar=no, location=no, directories=no, status=no, menubar=no, scrollbars=no, resizable=no, copyhistory=no, width=600, height=600, top='+top+', left='+left); jQuery(document).ready(function($) //asdasdasd $("#rcp-login").attr('href',' _to= -issues/november-1-2017-vol-37-no-19/'); ) jQuery(document).ready(function($) $("#rcp-reg").attr('href',' -your-gen-account?level=2&redirect_to= -issues/november-1-2017-vol-37-no-19/'); $("#rcp-reg2").attr('href',' -your-gen-account?level=2&redirect_to= -issues/november-1-2017-vol-37-no-19/'); ) jQuery(document).ready(function($){ $(".rcp_message").before(' Welcome to GEN Edge!If you are a brand new GEN website user, a verification link has been sent to your email account.If you already had a free GEN website account and just upgraded to GEN Edge, you do not need to verify your email.If you are a brand new GEN website user, please click on the link that has just been sent to your email account to verify your email. You will then be able to read GEN Edge articles and content. If you dont see the email in your inbox please check your junk/spam folder for it.If you need assistance please email gen-edge-support@genengnews.com
CenterDateTimeLocationCBERNovember 30- December 1, 2017November 30, 2017 from 8:00 a.m. to approximately 5:45 p.m. andDecember 1, 2017 from 8:00 a.m. to approximately 3:30 p.m.10903 New Hampshire Avenue.,Building 31 Conference Center,The Great Room, room 1503.Silver Spring, MD 20993-0002AgendaOn November 30, 2017, the committee members will meet in open session to discuss bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion. In the afternoon, the Committee will be seated as a device classification panel. In open session, the panel will discuss the appropriate device classification of human leukocyte antigen, human platelet antigen and human neutrophil antigen devices. On December 1, 2017, the committee members will meet in open session to discuss strategies to reduce the risk of transfusion-transmitted Zika virus. In the afternoon, an information session on the Transfusion Transmissible Infections Monitoring System will be presented to the Committee. Finally, the Committee will hear an update presentation on the April 6, 2017 FDA public workshop on emerging tick-borne diseases and blood safety.
November 01st, 2017
The arbitration rule became effective on September 18, 2017, with a March 19, 2018, mandatory compliance date. Under the CRA, enactment of a resolution of disapproval blocks a rule from taking effect or continuing. Accordingly, the signing of the joint resolution by President Trump means the CFPB arbitration rule is no longer effective. 2ff7e9595c
Comments